Skip to content
healthcare.dev
Get a free key

Allergy Relief

NDC 68998-194, Cetirizine hydrochloride, tablet, coated, from MARC GLASSMAN, INC..

Product NDC
68998-194
Status
Listed
Labeler
MARC GLASSMAN, INC.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209274
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68998-194 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
68998-194-02689980194021 BOTTLE, PLASTIC in 1 CARTON (68998-194-02) / 30 TABLET, COATED in 1 BOTTLE, PLASTIC
68998-194-07689980194071 BOTTLE, PLASTIC in 1 CARTON (68998-194-07) / 90 TABLET, COATED in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68998-194 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68998-194 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68998-194. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.